ArticleNeurosurgical review2025
Readmission patterns and 6-month outcomes in patients with spontaneous intracerebral hematoma: a single centre retrospective analysis in Ghana.
Article in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hospital readmissions following spontaneous intracerebral hemorrhage (sICH) are a significant concern in Ghana. The paper explores readmission rates and influencing factors. Adult patients with sICH between 2021 and 2023 were reviewed to evaluate readmission rates and associated factors. Statistical analyses were performed using Wilcoxon rank sum and chi-square tests comparing non-readmitted and readmitted groups. The study included 102 patients, of which 82.4% (84) were not readmitted and 17.6% (18) were re-admitted. The median age of patients in the non-readmitted group was 50 years (Interquartile range [IQR]: 44-60) vs. 60.5 years (IQR: 50-71.5). Regarding gender, 61 patients (72.6%) in the non-readmitted group were male, while the readmitted group had an equal number of males and females (9 each, 50.0%). Hypertension was the most prevalent comorbidity in both groups, observed in 71 patients (85.5%) vs. 15 patients (83.3%). Most patients were managed conservatively, with 88.1% of non-readmitted patients and 77.8% of readmitted patients receiving conservative treatment (p = 0.265). The median hospital length of stay was 8.5 days (IQR: 4-14.8) vs. 5 days (IQR: 3-11, p = 0.094). The median modified rankin scale (mRS) score at 1-month post-discharge was 2.0 (IQR: 0.5-4) for the non-readmitted group and 3.5 (IQR: 3-4) for the readmitted group (p = 0.225). At 6 months post-discharge, the median mRS score was 1 (IQR: 0-3) in the non-readmitted group and 3.5 (IQR: 3-4) in the readmitted group (p = 0.072). Readmitted patients had a higher median age, greater prevalence of diabetes, and worse functional outcomes at 1- and 6-month follow-ups. These findings highlight the need for comprehensive discharge planning and post-discharge support for sICH patients, particularly those with diabetes and higher mRS scores. Tailored interventions and follow-up protocols can potentially reduce readmission rates and improve outcomes, warranting further research in this area.
Indexed as
Identifiers
40053184What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.